Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 11


"Robo-tripping": dextromethorphan abuse and its anesthetic implications.

Linn KA, Long MT, Pagel PS.

Anesth Pain Med. 2014 Nov 14;4(5):e20990. doi: 10.5812/aapm.20990. eCollection 2014 Dec.


Novel psychoactive substances of interest for psychiatry.

Schifano F, Orsolini L, Duccio Papanti G, Corkery JM.

World Psychiatry. 2015 Feb;14(1):15-26. doi: 10.1002/wps.20174.


A case of acute psychosis secondary to coricidin overdose.

Aytha SK, Dannaram S, Moorthy S, Sharma A.

Prim Care Companion CNS Disord. 2013;15(6). pii: PCC.13l01549. doi: 10.4088/PCC.13l01549. No abstract available.


Effect of a single dose of dextromethorphan on psychomotor performance and working memory capacity.

Al-Kuraishy HM, Al-Gareeb AI, Ashor AW.

Indian J Psychol Med. 2012 Apr;34(2):140-3. doi: 10.4103/0253-7176.101779.


Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson's disease: role of NMDA vs. 5-HT1A receptors.

Paquette MA, Martinez AA, Macheda T, Meshul CK, Johnson SW, Berger SP, Giuffrida A.

Eur J Neurosci. 2012 Nov;36(9):3224-34. doi: 10.1111/j.1460-9568.2012.08243.x. Epub 2012 Aug 3.


Dextromethorphan withdrawal and dependence syndrome.

Mutschler J, Koopmann A, Grosshans M, Hermann D, Mann K, Kiefer F.

Dtsch Arztebl Int. 2010 Jul;107(30):537-40. doi: 10.3238/arztebl.2010.0537. Epub 2010 Jul 30.


Search for the "ideal analgesic" in pain treatment by engineering the mu-opioid receptor.

Tao PL, Law PY, Loh HH.

IUBMB Life. 2010 Feb;62(2):103-11. doi: 10.1002/iub.292. Review.


The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Paquette MA, Foley K, Brudney EG, Meshul CK, Johnson SW, Berger SP.

Psychopharmacology (Berl). 2009 Jul;204(4):743-54. doi: 10.1007/s00213-009-1505-8. Epub 2009 Mar 13. Erratum in: Psychopharmacology (Berl). 2009 May;204(1):185-7.


Sigma ligands, but not N-methyl-D-aspartate antagonists, reduce levodopa-induced dyskinesias.

Paquette MA, Brudney EG, Putterman DB, Meshul CK, Johnson SW, Berger SP.

Neuroreport. 2008 Jan 8;19(1):111-5. doi: 10.1097/WNR.0b013e3282f3b0d1.


Glioblastoma: looking at the currently marketed sigma-1 agonists and antagonists.

Kast RE.

Neoplasia. 2007 Aug;9(8):689. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk